Clinical characteristics and programmed cell death ligand-1 expression in adenocarcinoma in situ and minimally invasive adenocarcinoma of lung.

about

Clinical characteristics and programmed cell death ligand-1 expression in adenocarcinoma in situ and minimally invasive adenocarcinoma of lung.

Item

http://www.wikidata.org/entity/Q47117334

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Clinical characteristics and p ...... vasive adenocarcinoma of lung.

@en

Clinical characteristics and p ...... vasive adenocarcinoma of lung.

@nl

type

Item

label

Clinical characteristics and p ...... vasive adenocarcinoma of lung.

@en

Clinical characteristics and p ...... vasive adenocarcinoma of lung.

@nl

prefLabel

Clinical characteristics and p ...... vasive adenocarcinoma of lung.

@en

Clinical characteristics and p ...... vasive adenocarcinoma of lung.

@nl

P1476

Clinical characteristics and p ...... vasive adenocarcinoma of lung.

@en

P2093

Hanliang Jiang

http://www.w3.org/2001/XMLSchema#string

Hongming Pan

http://www.w3.org/2001/XMLSchema#string

Renke Yu

http://www.w3.org/2001/XMLSchema#string

Weidong Han

http://www.w3.org/2001/XMLSchema#string

Ying Lou

http://www.w3.org/2001/XMLSchema#string

Yuhui Wu

http://www.w3.org/2001/XMLSchema#string

Zhen Liu

http://www.w3.org/2001/XMLSchema#string

Zhengfu He

http://www.w3.org/2001/XMLSchema#string

P2860

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

Reduced lung-cancer mortality with low-dose computed tomographic screening

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma

Cancer statistics, 2016

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer

Prognosis and status of lymph node involvement in patients with adenocarcinoma in situ and minimally invasive adenocarcinoma-a systematic literature review and pooled-data analysis.

Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease

Does lung adenocarcinoma subtype predict patient survival?: A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung

P304

97801-97810

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.22082

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29228652

http://www.w3.org/2001/XMLSchema#string

P921

adenocarcinoma

P932

5716692

http://www.w3.org/2001/XMLSchema#string